How to work with a supplement manufacturer for UK brands

UK brands selling through both retail and direct-to-consumer channels often find that a format suited to a shelf listing (a bottle-packed gummy, for instance) is not necessarily the format suited to a subscription or travel-focused D2C offer (a sachet or a dropper bottle travels more easily and suits smaller repeat-order formats). Since the catalogue's six commercial formats — gummies, sachets, functional jellies, oral strips, liquid drops, pet soft chews — are all sourced from the same manufacturing relationship, a UK brand can plan a retail-first SKU and a D2C-first SKU without switching partners between the two.

Deciding this early, at the brief stage, means your packaging and label layout are designed for the channel each SKU is actually going to, rather than a single generic pack trying to serve both.

A UK brand doesn't need to commit to a single product category on day one — the catalogue spans a wide set of categories (daily vitamins, sports nutrition, beauty & skin, gut & digestion, and others), and many UK brands use a first SKU in one category to establish the manufacturing relationship, documentation pattern and packaging system before expanding into an adjacent category as a second phase.

This sequencing mirrors how a multi-format range is typically planned — start with what has clear market fit and existing catalogue support, then extend once the working relationship with the manufacturer's project team is established.

A UK brand that also intends to list in EU markets doesn't necessarily need a second manufacturing relationship for the EU side — a partner already serving both UK and EU storefronts can supply both from the same catalogue and documentation baseline, which keeps your specification, certificate of analysis and formulation records consistent across the markets you're launching into rather than reconciling two separate paper trails.

Final label compliance still has to be reviewed per destination market by you as the brand owner, since UK and EU labelling requirements aren't identical even when the underlying product is — but sourcing from one partner removes the operational duplication of managing two production relationships to serve two adjacent markets.

UK and EU supplement labelling share a great deal of common ground — nutrient declarations and allergen statements follow broadly similar logic in both markets — but they aren't identical, and a label built only for one market doesn't automatically clear the other. Rather than treating this as a reason to default to one market first, many UK brands plan both label variants from the brief stage, since the underlying product and documentation are the same either way — only the label artwork and specific claim wording need a market-by-market review.

This review sits with you as the brand owner in both markets; the manufacturer can supply the same specification and certificate of analysis to support either label, but confirming what's permitted to say on each remains a per-market check.

For a UK brand's first order, the sequence is the same regardless of which catalogue format you've chosen: brief, sample, sign-off, then production on the manufacturer's standard 8–12 week timeline. What's UK-specific is what happens in parallel with that sequence — your own label and market-compliance review, which can run alongside sampling and production rather than waiting for either to finish.

Brand owners who treat the UK-specific review as a late-stage task, after production starts, are the ones most likely to find themselves waiting on label approval after the physical product is already ready — running it in parallel from the brief stage avoids that gap.